Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangshun Tan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Mini Reviews in Medicinal Chemistry|May 17, 2022
ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer TypesFangshun Tan
Journal of Physiology and Biochemistry|December 20, 2024
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseasesJingjie Yang, Fangshun Tan, Yaohui Chen, et al.
Mini Reviews in Medicinal Chemistry|April 15, 2024
The Pivotal Function of SLC16A1 and SLC16A1-AS1 in Cancer Progress: Molecular Pathogenesis and PrognosisYunxi Zhou, Fangshun Tan, Zhuowei Wang, et al.
Current Pharmaceutical Design|May 1, 2022
ITGA9: Potential Biomarkers and Therapeutic Targets in Different TumorsYinxin Wu, Jinlan Chen, Fangshun Tan, et al.
Current Pharmaceutical Design|March 11, 2022
MIR17HG: A Cancerogenic Long-Noncoding RNA in Different CancersFangshun Tan, Jinlan Chen, Zhuoying Du, et al.
Mini Reviews in Medicinal Chemistry|August 27, 2022
The Dual Functions of Non-Coding RNA CRNDE in Different TumorsZhuowei Wang, Yinxin Wu, Zhuoyin Du, et al.
Current Medicinal Chemistry|September 19, 2022
Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple CancersFangnan Zhao, Fangshun Tan, Lu Tang, et al.
Current Pharmaceutical Design|September 28, 2021
OIP5-AS1: A Fascinating Long Noncoding RNA in CarcinomaJuanjuan Zhong, Jinlan Chen, Bei Wang, et al.
Current Pharmaceutical Design|June 8, 2022
MIR4435-2HG: A Tumor-associated Long Non-coding RNAFangnan Zhao, Yuling Liu, Fangshun Tan, et al.
Current Pharmaceutical Design|May 27, 2022
HNF1A-AS1: A Tumor-associated Long Non-coding RNAYuling Liu, Fangnan Zhao, Fangshun Tan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Mini Reviews in Medicinal Chemistry|May 17, 2022
ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer TypesFangshun Tan
Journal of Physiology and Biochemistry|December 20, 2024
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseasesJingjie Yang, Fangshun Tan, Yaohui Chen, et al.
Mini Reviews in Medicinal Chemistry|April 15, 2024
The Pivotal Function of SLC16A1 and SLC16A1-AS1 in Cancer Progress: Molecular Pathogenesis and PrognosisYunxi Zhou, Fangshun Tan, Zhuowei Wang, et al.
Current Pharmaceutical Design|May 1, 2022
ITGA9: Potential Biomarkers and Therapeutic Targets in Different TumorsYinxin Wu, Jinlan Chen, Fangshun Tan, et al.
Current Pharmaceutical Design|March 11, 2022
MIR17HG: A Cancerogenic Long-Noncoding RNA in Different CancersFangshun Tan, Jinlan Chen, Zhuoying Du, et al.
Mini Reviews in Medicinal Chemistry|August 27, 2022
The Dual Functions of Non-Coding RNA CRNDE in Different TumorsZhuowei Wang, Yinxin Wu, Zhuoyin Du, et al.
Current Medicinal Chemistry|September 19, 2022
Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple CancersFangnan Zhao, Fangshun Tan, Lu Tang, et al.
Current Pharmaceutical Design|September 28, 2021
OIP5-AS1: A Fascinating Long Noncoding RNA in CarcinomaJuanjuan Zhong, Jinlan Chen, Bei Wang, et al.
Current Pharmaceutical Design|June 8, 2022
MIR4435-2HG: A Tumor-associated Long Non-coding RNAFangnan Zhao, Yuling Liu, Fangshun Tan, et al.
Current Pharmaceutical Design|May 27, 2022
HNF1A-AS1: A Tumor-associated Long Non-coding RNAYuling Liu, Fangnan Zhao, Fangshun Tan, et al.
Pageof 2